Moderate psoriasis: the new frontier for systemic therapies UNVEIL trial shows apremilast hits the mark in this population. mdedge.com Topical tapinarof heads for phase 3 in atopic dermatitis and psoriasis mdedge.com
Optimized by Seraphinite Accelerator